Filing Details
- Accession Number:
- 0001209191-20-057212
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-05 19:52:56
- Reporting Period:
- 2020-11-03
- Accepted Time:
- 2020-11-05 19:52:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 860730 | Hca Healthcare Inc. | HCA | Services-General Medical & Surgical Hospitals, Nec (8062) | 273865930 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216838 | N Samuel Hazen | One Park Plaza Nashville TN 37203 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-03 | 93,750 | $17.33 | 154,516 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 15,625 | $21.35 | 170,141 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 12,500 | $22.10 | 182,641 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 250,000 | $22.95 | 432,641 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 185,250 | $37.18 | 617,891 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-03 | 227,540 | $136.09 | 390,351 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-11-03 | 5,000 | $136.63 | 385,351 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-03 | 72,776 | $135.90 | 312,575 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-03 | 44,099 | $135.02 | 268,476 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 46,875 | $0.00 | 46,875 | $17.33 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 46,875 | $0.00 | 46,875 | $17.33 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 15,625 | $0.00 | 15,625 | $21.35 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-03 | 12,500 | $0.00 | 12,500 | $22.10 |
| Common Stock | Stock Appreciation Right | Disposition | 2020-11-03 | 125,000 | $0.00 | 125,000 | $22.95 |
| Common Stock | Stock Appreciation Right | Disposition | 2020-11-03 | 125,000 | $0.00 | 125,000 | $22.95 |
| Common Stock | Stock Appreciation Right | Disposition | 2020-11-03 | 95,000 | $0.00 | 95,000 | $37.18 |
| Common Stock | Stock Appreciation Right | Disposition | 2020-11-03 | 90,250 | $0.00 | 90,250 | $37.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-11-02 | No | 4 | M | Direct | |
| 0 | 2021-11-02 | No | 4 | M | Direct | |
| 0 | 2012-11-02 | 2021-11-02 | No | 4 | M | Direct |
| 0 | 2021-11-02 | No | 4 | M | Direct | |
| 0 | 2022-02-08 | No | 4 | M | Direct | |
| 0 | 2022-02-08 | No | 4 | M | Direct | |
| 0 | 2023-02-06 | No | 4 | M | Direct | |
| 0 | 2023-02-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 813,320 | Indirect | By LP |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.50 to $136.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.44 to $136.43, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.44 to $135.43, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vested in three equal annual installments beginning on November 2, 2013.
- The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets.
- The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets.
- The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
- The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
- The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
- The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
Billionaire Hedge Funds
